Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

NCT01259817 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

High Risk Polycythemia Vera
High Risk Essential Thrombocythemia

Interventions

DRUG: PEGASYS
DRUG: Aspirin

Sponsor

Ronald Hoffman

Collaborators

[object Object]
[object Object]
[object Object]